Search results for "Paresthesia"

showing 10 items of 19 documents

Clinical evaluation criteria for the assessment of impaired pain sensitivity by thulium-laser evoked potentials

2000

Abstract Objectives : Cortical potentials evoked by carbon dioxide laser pulses have been applied in clinical practice to study nociceptive pathways for several years. In this study, we evaluate the properties of an infrared laser (thulium-YAG) with a penetration depth in the skin that matches the intracutaneous depth of nociceptors. Methods : Temperature measurements and modelling showed that the thulium laser generates painful intracutaneous temperatures with less surface heating than the carbon dioxide laser and with no side effects (up to 600 mJ pulse energy). To develop clinical evaluation criteria, laser-evoked potentials (LEPs) were recorded from 3 midline positions (Fz, Cz, Pz) vers…

AdultMalePain Thresholdmedicine.medical_specialtyLaser-Evoked PotentialsInfrared Raysmedicine.medical_treatmentAudiologyEvoked Potentials SomatosensoryPhysiology (medical)medicineNoxious stimulusHumansNeurons AfferentParesthesiaHabituationHabituation Psychophysiologicbusiness.industryElectrodiagnosisLasersNociceptorsReproducibility of ResultsDissociated sensory lossElectroencephalographyMiddle AgedCarbon dioxide lasermedicine.diseaseSensory SystemsElectrophysiologyNociceptionNeurologySomatosensory evoked potentialThuliumAnesthesiaFemaleNeurology (clinical)businessClinical Neurophysiology
researchProduct

Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

2002

Anderson-Fabry disease is a rare, X-chromosomal lipid storage disorder caused by a deficiency of lysosomal alpha-galactosidase A. Clinical manifestations of Anderson-Fabry disease include excruciating pain in the extremities (acroparaesthesia), skin vessel ectasia (angiokeratoma), corneal and lenticular opacity, cardiovascular disease, stroke and renal failure, only renal failure being a frequent cause of death. Heterozygote female carriers have often been reported as being asymptomatic or having an attenuated form of the disease. To evaluate the spectrum of clinical signs in heterozygotes, a comprehensive clinical examination was performed on 20 carriers of Anderson-Fabry disease. This rev…

AdultMalePathologymedicine.medical_specialtyHeterozygoteX ChromosomeLipid storage disorderAdolescentHeart DiseasesGastrointestinal DiseasesPhysical examinationDiseaseAsymptomaticGlycosphingolipidsGeneticsmedicineHumansParesthesiaChildGenetics (clinical)Cause of deathmedicine.diagnostic_testVascular diseasebusiness.industrymedicine.diseaseFabry diseaseDermatologyAngiokeratomaCerebrovascular DisordersChild PreschoolBlood VesselsFabry DiseaseFemaleKidney Diseasesmedicine.symptombusinessJournal of inherited metabolic disease
researchProduct

Two-rescuer CPR results in hyperventilation in the ventilating rescuer.

2005

The "Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care--International Consensus on Science" recommend a tidal ventilation volume of 10 ml/kg body-weight without the use of supplemental oxygen during two-rescuer adult cardiopulmonary resuscitation (CPR). This relates to a ventilation volume of about 6.4 l/min. Additionally, the first aid provider ventilating the victim will breathe for him/herself during the external chest compression period adding another 3.2 l/min of ventilation. Finally, a deep breath is recommended before each ventilation to increase the end-expiratory oxygen concentration of the air exhaled. To investigate the effects of these recommend…

AdultMaleResuscitationmedicine.medical_treatmentBlood PressureEmergency NursingDizzinesslaw.inventionlawHeart RateIntensive careHeart rateHyperventilationMedicineHumansHyperventilationCardiopulmonary resuscitationParesthesiaOxygen saturation (medicine)business.industryCarbon DioxideCardiopulmonary ResuscitationBlood pressureCaregiversAnesthesiaVentilation (architecture)Emergency MedicineFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

Time course of adverse events most commonly associated with topiramate for migraine prevention

2007

The efficacy, safety and tolerability of topiramate has been demonstrated in three large multicenter, randomized, double-blind, placebo-controlled trials. To characterize the time course of adverse events (AEs) that led to treatment discontinuation in/=2% of patients who received topiramate 100 mg/day during three pivotal, multicenter, randomized, double-blind, placebo-controlled, and 26-week trials. The pooled population comprised all randomized patients who reported safety data during the double-blind phase (topiramate 100 mg/day, n = 386; placebo n = 372), which consisted of a 4-week titration period and a 22-week maintenance period. Incidence, time to onset, and cumulative mean rate of …

AdultMaleTopiramateTime FactorsNauseaMigraine DisordersPopulationFructosePlaceboTimelaw.inventionPlacebosDouble-Blind MethodRandomized controlled trialTopiramatelawmedicineHumansParesthesiaeducationFatigueeducation.field_of_studyDose-Response Relationship Drugbusiness.industryNauseaMiddle Agedmedicine.diseaseAnorexiaDiscontinuationWithholding TreatmentNeurologyTolerabilityMigraineAnesthesiaPatient ComplianceAnticonvulsantsFemaleNeurology (clinical)medicine.symptomCognition Disordersbusinessmedicine.drugEuropean Journal of Neurology
researchProduct

Treatment of injuries to the inferior alveolar nerve after endodontic procedures.

1998

Overextension of filling material into the mandibular canal after root treatment in the lower jaw is a rare but serious complication. Mechanical compression, chemical neurotoxicity and local infection may cause irreversible nerve damage. A report on 11 patients with neurological complaints of the inferior alveolar nerve after endodontic treatment is summarised. The neurological findings are dominated by hypaesthesia and dysaesthesia. Half of the patients reported pain. Hyperaesthesia is found much more rarely. Nearly all the patients had a combination of one or more symptoms. Initial X-rays showed root filling material in the area of the mandibular canal. Nine cases were treated with apicec…

AdultMalemedicine.medical_specialtyDecompressionmedicine.medical_treatmentMandibular NerveDentistryMandibular canalInferior alveolar nerveApicectomyHypesthesiaRoot Canal Filling Materialsstomatognathic systemmedicineHumansParesthesiaGeneral DentistryENDODONTIC PROCEDURESbusiness.industryNerve Compression SyndromesApicoectomyNerve injuryMiddle AgedDecompression SurgicalSurgeryRoot Canal Therapystomatognathic diseasesmedicine.anatomical_structureApicoectomyTooth ExtractionNeuralgiaFemaleTrigeminal Nerve Injuriesmedicine.symptombusinessComplicationFollow-Up StudiesClinical oral investigations
researchProduct

Repair of the mandibular nerve by means of autologous nerve grafting after resection of the lower jaw

1973

Summary On the basis of two cases we demonstrate our method of autologous nerve grafting for substitution of the mandibular nerve after mandibular resection. The sural nerve served as a donor nerve, the graft was imbedded microsurgically at the juncture points by means of a perineurial interfascicular nerve suture. Oversized grafts of about 20 cm in length were chosen intentionally in order to insert them without tension between the stumps of the recipient nerve and outside the regeneration zone of the bone. In both cases complete resensibilization of the lower lip was reached after about six months.

AdultMicrosurgerymedicine.medical_specialtyMandibular NerveMandibular nerveLower lipSural nerveTransplantation AutologousResectionAmeloblastomaPostoperative ComplicationsSural Nervestomatognathic systemmedicineHumansParesthesiaChildNerve graftingbusiness.industryGeneral MedicineAnatomyDenervationMandibular resectionLipNerve RegenerationOsteotomySurgeryMandibular Neoplasmssurgical procedures operativeFemaleSurgeryEpineurial repairNerve suturebusinessJournal of Maxillofacial Surgery
researchProduct

Volume and effectiveness assessment of articain 4% versus mepivacaine 2% used in third molar surgery : randomized, double-blind, split-mouth controll…

2020

Made available in DSpace on 2021-06-25T11:06:11Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-01-01 Background: The different indications for extraction of the lower third molars, require resources to manage pain and discomfort, such as, for example, adequate anesthetic techniques, and the type of anesthetic used can in-fluence the management of pain in tooth extractions. Few studies in the literature compare the anesthetics 4% articaine hydrochloride and 2% mepivacaine hydrochloride showing evidence that both allow for successful pain management. This study sought to compare the volume, efficacy and safety of these two anesthetic drugs, both associated with epinephrine at a ratio …

Local anaesthesiaVisual analogue scaleAnesthesia DentalMepivacainePainCarticaineArticaineArticaine Hydrochloridelaw.inventionCarticaineRandomized controlled trialDouble-Blind MethodlawThird molarmedicineHumansParesthesiaAnesthetics LocalGeneral Dentistrybusiness.industryResearch:CIENCIAS MÉDICAS [UNESCO]Clinical trialOtorhinolaryngologyAnesthesiaAnestheticMepivacaineTooth ExtractionUNESCO::CIENCIAS MÉDICASSurgeryMolar ThirdOral Surgerybusinessmedicine.drug
researchProduct

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

2018

Abstract Aim of the study The optimal therapeutic strategy in patients with rectal cancer and synchronous unresectable metastases remains unknown. We evaluated the efficacy of FOLFIRINOX induction therapy in this setting. Patients and methods Chemotherapy-naive patients received at least 8 cycles of FOLFIRINOX. The primary end-point was the 4-month disease control (4 m DC) rate. Tumour responses were centrally reviewed and assessed by computed tomography scan for metastases (Response Evaluation Criteria in Solid Tumours criteria) and magnetic resonance imaging for rectal tumorus. With a Simon 2-stage design and a targeted (H1) 4 m DC > 75%, 65 patients were enrolled from July 2012 to Februa…

MaleCancer ResearchLung NeoplasmsColorectal cancerFOLFIRINOXGastrointestinal DiseasesSynchronous metastasesLeucovorinKaplan-Meier EstimateInduction0302 clinical medicineInduction therapyAntineoplastic Combined Chemotherapy ProtocolsRectal cancerINDUCTION TREATMENTFatigueResponse rate (survey)medicine.diagnostic_testLiver NeoplasmsRemission InductionMiddle AgedCombined Modality TherapyMagnetic Resonance ImagingProgression-Free Survival3. Good healthOxaliplatinFOLFIRINOXTreatment OutcomeOncology030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleRadiologyFluorouracilAdultmedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/CancerAdenocarcinomaIrinotecan03 medical and health sciencesmedicineHumansParesthesiaAgedPerformance statusbusiness.industryRectal NeoplasmsMagnetic resonance imagingmedicine.diseaseHematologic DiseasesConfidence intervalLocal controlbusinessTomography X-Ray ComputedFollow-Up Studies
researchProduct

Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems

2012

Cobalamin (vitamin B12) deficiency occurs with several disorders, involving different organs and systems, including blood, bowel, nervous system and eyes. Although the most important features are usually haematological ones, presence of neurological involvement, in the absence of blood count alterations, has just been described in the literature. Here we report the case of a 48-year-old man, suffering from coeliac disease for approximately 5 years, vegetarian, who was admitted to our department, referring dysaesthesia of the left lower limb, decreased libido and erectile dysfunction. Vitamin B12 deficiency was proved, even in the absence of blood count alteration, and treated with a vitamin…

MaleNervous systemmedicine.medical_specialtyMultiple SclerosisSettore MED/09 - Medicina InternaGastroenterologyCobalaminArticleCoeliac diseaseDiagnosis DifferentialMultiple sclerosis; coeliac diseasechemistry.chemical_compoundFolic AcidErectile DysfunctionInternal medicinemedicineHumansMultiple sclerosiParesthesiaVitamin B12business.industryMultiple sclerosisBrainVitamin B 12 DeficiencyGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingDecreased LibidoSurgeryCeliac DiseaseErectile dysfunctionmedicine.anatomical_structureSpinal CordchemistryVitamin B ComplexDifferential diagnosisbusinesscoeliac disease
researchProduct

Dysynchiria is not a common feature of neuropathic pain

2006

Patients with chronic neuropathic pain (non-CRPS) and brush-evoked allodynia watched a reflected image of their corresponding but opposite skin region being brushed in a mirror. Unlike complex regional pain syndrome Type 1, this process did not evoke any sensation at the affected area ('dysynchiria'). We conclude that central nociceptive sensitisation alone is not sufficient to cause dysynchiria in neuropathic pain. The results imply a difference in cortical pain processing between complex regional pain syndrome and other chronic neuropathic pain.

MalePain Thresholdmedicine.medical_specialtyPhysical medicine and rehabilitationThreshold of painmedicineHumansParesthesiaReferred painbusiness.industrydysynchiria; CRPS; neuropathic painNociceptorsMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineComplex regional pain syndromeAllodyniaNociceptionAnesthesiaChronic DiseaseNeuropathic painOther Psychology and Cognitive SciencesNeuralgiaNociceptorNeuralgiaFemalemedicine.symptombusinessEuropean Journal of Pain
researchProduct